Showing results (511-520 of 2,958) with videos related to

Sort By:
Pageof 296
Molecular Medicine (Cambridge, Mass.)|February 26, 2015
Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cellsLili Gao, Wei Tang, ZhengZheng Ding, et al.
Molecular Medicine (Cambridge, Mass.)|May 24, 2023
Rad1 attenuates DNA double-strand breaks and cell cycle arrest in type II alveolar epithelial cells of rats with bronchopulmonary dysplasiaXin Tong, Danni Li, Na Liu, et al.
Molecular Medicine (Cambridge, Mass.)|April 17, 2015
Resveratrol Improves Survival and Prolongs Life Following Hemorrhagic ShockAhmar Ayub, Ninu Poulose, Raghavan Raju
Molecular Medicine (Cambridge, Mass.)|April 17, 2015
Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 SignalingYung-Ming Chen, Wen-Chih Chiang, Yalin Yang, et al.
Molecular Medicine (Cambridge, Mass.)|June 27, 2020
Correction to: Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivoLamia Heikal, Pietro Ghezzi, Manuela Mengozzi, et al.
Molecular Medicine (Cambridge, Mass.)|April 14, 2021
Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signalingJing Cui, Yao Guo, Heshui Wu, et al.
Molecular Medicine (Cambridge, Mass.)|April 16, 2021
LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microgliaLi-Qing Wang, Yue-Ying Zheng, Heng-Jun Zhou, et al.
Molecular Medicine (Cambridge, Mass.)|May 10, 2023
Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylationYilin Tao, Chengyuan Tang, Ju Wei, et al.
Molecular Medicine (Cambridge, Mass.)|January 8, 2014
Resveratrol restores sirtuin 1 (SIRT1) activity and pyruvate dehydrogenase kinase 1 (PDK1) expression after hemorrhagic injury in a rat modelBixi Jian, Shaolong Yang, Irshad H Chaudry, et al.
Molecular Medicine (Cambridge, Mass.)|January 8, 2014
Decline in serum cholinesterase activities predicts 2-year major adverse cardiac eventsYaron Arbel, Shani Shenhar-Tsarfaty, Nir Waiskopf, et al.
Pageof 296